Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The α-Gal epitope (galactose-α-1,3-galactose) is a carbohydrate antigen with the canonical structure Galα1–3Galβ1–4GlcNAc that is highly expressed on glycoproteins and glycolipids of non-primate mammals and New World monkeys but not in humans, apes, or Old World monkeys due to inactivation of the α1–3-galactosyltransferase enzyme[3][5][7]. In humans, the immune system produces abundant natural antibodies against the α-Gal epitope, especially IgM, IgG, and IgA, as a result of exposure to gut microbiota and environmental sources[5][7]. In susceptible individuals, repeated tick bites can induce production of IgE antibodies to α-Gal, leading to α-Gal syndrome, a form of delayed anaphylaxis to red meat and mammalian products, and occasionally immediate hypersensitivity to injected or implanted materials containing α-Gal[1][3][5]. The structural similarity to the blood group B antigen means people with blood group B or AB have some protection against developing α-Gal syndrome[8]. The α-Gal epitope is also a significant immunological barrier in xenotransplantation, as natural anti-Gal antibodies in humans rapidly reject transplanted tissue expressing this epitope[4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Galactose-α-1,3-galactose epitope (α-Gal).